Collaborative robots are improving efficiency in pharmaceutical research, drug production, and quality control. Collaborative robots offer pharmaceutical applications greater reliability, consistency, and precision.

Robotics as a Service (RaaS), which allows manufacturers to leverage the benefits of industrial and collaborative robots in their facility without having to buy them, is becoming popular.

The robots of the future will benefit from technology advances such as increased human-robot interaction, increased mobility, and multi-robot coordination.

The robots of the future will exceed the capabilities of today’s robots. They will be able to automating tasks that were previously impossible. Many of these robots of tomorrow–the ones that will transform the way we work, the way we travel, the way we purchase items and more–are under development today.

Implementing industrial robots in a manufacturing setting isn’t as simple as buying the robot and plugging it in. There are many different financial and logistical considerations to take into account before a robot can productively automate anything. While industrial robots may serve a wide variety of purposes, the challenges manufacturers face when implementing them are relatively similar.